Abstract: Effi cient phagocytosis of cells undergoing apoptosis by macrophages is important to prevent immunological responses and development of chronic infl ammatory disorders such as systemic lupus erythematosus, cystic fi brosis and atherosclerosis. To study phagocytosis of apoptotic cells (AC) by macrophages in tissue, we validated different apoptosis markers (DNA fragmentation, caspase-3 activation and cleavage of its substrate poly(ADP-ribose)polymerase-1) in combination with macrophage immunostaining. Human tonsils were used as a model because they show a high apoptosis frequency under physiological conditions as well as effi cient phagocytosis of AC by macrophages. On the other hand, advanced human atherosclerotic plaques were examined since plaques show severely impaired phagocytosis of AC. Our results demonstrate that the presence of non-phagocytized terminal deoxynucleotidyl transferase end labelling (TUNEL)-positive AC represents a suitable marker of poor phagocytosis by macrophages in situ. Other markers for apoptosis, such as cleavage of caspase-3 or PARP-1, should not be used to assess phagocytosis effi ciency, because activation of the caspase cascade and cleavage of their substrates can occur in AC when they have not yet been phagocytized by macrophages.
Introduction
Apoptosis or type I programmed cell death is an essential process during morphogenesis, tissue homeostasis and immune regulation and is involved in the elimination of infected, damaged or unwanted cells (Wyllie, 1992) . The organelles and plasma membrane of apoptotic cells (AC) typically remain intact, avoiding proinfl ammatory spilling of the cellular content into the surrounding tissue. In this light, the apoptotic process has long been considered immunologically silent. However, recent evidence suggests that AC may also contribute to infl ammatory processes via the release of pro-infl ammatory cytokines (Hogquist et al. 1991) and/or chemotactic factors (Lauber et al. 2003) . Moreover, ineffi cient removal of AC may lead to induction of postapoptotic necrosis and infl ammatory responses. To prevent infl ammation, cells signal their apoptotic state at an early stage to their environment, where they are recognized and engulfed by phagocytes (Fadok et al. 2001) . Surface exposure of phosphatidylserine (PS) is one of these "eat-me" signals. To facilitate engulfment, apoptotic cells reduce their volume, contract their reorganized cytoskeleton and disintegrate into many small apoptotic bodies. Overall shrinkage is usually accompanied by nuclear condensation and internucleosomal DNA-fragmentation. Activation of the caspase family of cysteine proteases, in particular caspase-3, seems to be important in the latter process, as different caspase-3 -/-cell types, although still susceptible to certain apoptotic stimuli, show a complete absence of DNA fragmentation (Woo et al. 1998) . Moreover, specifi c subsets of proteins are cleaved by caspase-3 and other executioner caspases to produce the apoptotic phenotype. Among the proteins cleaved during apoptosis by caspase-3, poly(ADP-ribose) polymerase-1 (PARP-1) is one of the main cleavage targets.
At present, cleavage of caspase-3 and PARP-1 as well as fragmentation of DNA are well known biomarkers for apoptosis in tissue. They can be detected either via immunohistochemical techniques (cleaved caspase-3 and PARP-1) or via terminal deoxynucleotidyl transferase end labelling (TUNEL) of apoptotic cells (DNA fragmentation). Because rapid recognition and clearance of AC by phagocytes is essential for normal development and prevention of infl ammation and disease, phagocytosis of AC by macrophages has been extensively studied in chronic infl ammatory disorders to fully understand their pathophysiological role. Accordingly, poor phagocytosis of AC has been identifi ed in patients with systemic lupus erythematosis (SLE) (Ren et al. 2003) , chronic obstructive pulmonary disease (COPD) (Hodge et al. 2003) , cystic fibrosis (Vandivier et al. 2002) and atherosclerosis (Schrjvers et al. 2005) . However, to interpret clearance of apoptotic cells by phagocytes correctly, appropriate detection markers are needed (Nakamura et al. 1996) . Apoptosis in germinal centers of tonsils, as well as in lymph nodes, is a key regulatory event to eliminate non-and autoreactive lymphocytes. Nearly all AC in germinal centers of human tonsils are engulfed by macrophages, pointing toward a highly effi cient recognition and elimination process of AC (Baumann et al. 2002) . Phagocytosis of AC by macrophages in atherosclerotic plaques is severely impaired due to several factors, including cytoplasmic saturation, oxidative stress and competitive inhibition for common epitopes (Schrijvers et al. 2005) . In the present study, we compared different in situ markers for apoptosis (caspase-3 activation, PARP-1 cleavage and DNA fragmentation [TUNEL] ) to assess the effi ciency of phagocytosis of AC by macrophages in non-inflamed human tonsils and advanced human atherosclerotic plaques.
Methods

Human specimens
Human non-infl amed hyperplastic tonsils (n = 8) were obtained from patients (mean age = 28 ± 9 years, 50% men) undergoing tonsillectomies. Human carotid endarterectomy specimens (n = 10) were obtained from patients (71 ± 3 years, 70% men) with a carotid stenosis of >70%. Specimens were fi xed in 4% formalin within 2 min after surgical removal and paraffi n embedded.
Cell culture
In vitro experiments were performed using the murine macrophage cell line J774A.1 and the human monocyte cell line U937 (American Type Culture Collection). Cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, 20 U/ml polymyxin B and 50 µg/ml gentamycin. Cell culture media and supplements were from Invitrogen, fetal bovine serum was purchased from Sigma. To evaluate phagocytosis of apoptotic cells in vitro, J774A.1 macrophages and U937 cells were co-cultured in RPMI containing 50 µM etoposide. Previously, we demonstrated that etoposide (Sigma) induces apoptosis in U937 cells (77 ± 1% annexin V positive AC and complete cleavage of caspase-3 after 4 hours incubation without induction of necrosis (incorporation of propidium iodide)), but not in J774A.1 macrophages (Schrijvers et al. 2004 ). To prepare artifi cial cell blocks, cells were collected by scraping and centrifuged (900 × g, 7 min). Three drops of fi brinogen-rich plasma were added to the cell pellet. Subsequently, the pellet was detached from the tube using a wooden stick and three drops of thrombin (100 U/ml) were added. After shaking, cells were fi xed in 6% formol for 1 h. The cell pellet was dehydrated using isopropylalcohol and toluol and paraffi n embedded.
Flow cytometry
Control and apoptotic U937 cells were stained with 10 µM of the cell-permeant DNA staining compound DRAQ5 (Biostatus Ltd) according to manufacturer's instructions, and subsequently analysed by fl ow cytometry. Cell samples (20,000 cells/sample) were analyzed on a FACSort cytometer (BD Biosciences). Forward and side scatter gates were set to distinguish between viable and apoptotic cells. DRAQ5-emitted red fl uorescence was monitored in the FL 3 channel after excitation of the probe at 488 nm. Data were analyzed using Cell Quest Pro software (BD Biosciences).
Immunohistochemistry and terminal deoxynucleotidyl transferase end labelling (TUNEL)
Phagocytosis of AC by macrophages was examined by an indirect peroxidase antibody conjugate method using an anti-CD68 monoclonal antibody (clone PG-M1, DAKO) for macrophages, combined with an anti-cleaved caspase-3 polyclonal antibody (clone 67341A, Pharmingen) or an anti-cleaved PARP-1 p85 polyclonal antibody (Promega) to detect AC. The monoclonal antibody was detected using a goat-anti-mouse peroxidase secondary antibody (Jackson) for 45 minutes and visualized using Fast Blue as a chromogen. The polyclonal antibodies were detected by a PAP complex. For demonstration of the complex, 3-amino-9-ethyl carbazole (AEC) was used as a chromogen. Other primary antibodies used in this study were: anti-α-SMC actin (clone 1A4, Sigma), anti-vimentin (clone V9, DAKO) and anti-von Willibrand factor (The Binding Site Lt).
For the detection of oligonucleosomal DNA cleavage via TUNEL, tissue sections were pretreated with proteinase K for 10 minutes at 37°C and then rinsed with PBS. Subsequently, sections were incubated for 15 minutes at 37°C in a mixture containing 25 mM Tris-HCl, 0.25 mg/ml BSA, 200 mM potassium cacodylate, 5 mM CoCl 2 , 270 U/ml TdT (Roche), 10 µM dATP (Sigma) and 2.5 µM fluorescein-12-dUTP (Roche). Incorporated fl uorescein-dUTP was demonstrated with a sheep anti-fl uorescein peroxidase-conjugated antiserum (Boehringer Mannheim) at a dilution of 1/300 for 45 minutes and visualized by AEC. All TUNELpositive AC in whole mount sections of plaques (n = 10) were counted and included in the results. Because of the high number of cleaved PARP-1 and cleaved caspase-3 positive AC in plaques, labeled cells in fi ve random regions of interest around the necrotic core (120 × 100 µm each) were counted. In tonsils (n = 8), fi ve randomly chosen germinal centers were evaluated for phagocytosis of AC. AC were considered phagocytized when they were surrounded by macrophage cytoplasm. Since binding of AC to macrophages not automatically results in uptake, bound cells were always considered not ingested.
To colocalize TUNEL with cleaved caspase-3 immunoreactivity, TUNEL sections were destained with 1% hydrochloric acid in 70% ethanol, followed by an antigen retrieval method with citrate buffer treatment in a microwave oven. The sections were then immunostained as described above.
Results and Discussion
Human tonsils and atherosclerotic plaques were immunostained for CD68, a cell surface marker which is present on macrophages, in combination with (immuno-) histochemical detection of an in situ marker for apoptosis such as cleaved caspase-3, cleaved PARP-1 or TUNEL. The number of TUNEL-positive AC in whole mount sections of carotid plaque specimens amounted to 85 ± 10. In addition, numerous cleaved PARP-1 and cleaved caspase-3 positive cells were detected (53 ± 3 and 48 ± 8 per mm 2 , respectively). In tonsils, we counted per germinal center 17 ± 2 TUNEL-positive AC, 71 ± 13 cleaved PARP-1 positive AC and 79 ± 8 cleaved caspase-3 positive AC. Both in tonsils and atherosclerotic plaques the majority of cleaved caspase-3 and cleaved PARP-1 positive AC were located outside but still in close proximity of macrophages (Figure 1) . TUNEL positive AC in tonsils were found almost exclusively inside macrophages (Figure 1) . However, the majority of TUNELpositive AC in atherosclerotic plaques was not phagocytized, confi rming recent data that phagocytosis of AC by plaque macrophages is severely impaired. In vitro experiments with U937 monocytes undergoing apoptosis after etoposide treatment showed that the majority of apoptotic cells (>95%) contain nuclear DNA and thus can be detected by TUNEL (Figure 2 ). We may therefore conclude that TUNEL, but not cleaved caspase-3 and PARP-1, in combination with macrophage immunostaining is a suitable method for evaluation of phagocytosis of AC by macrophages.
To reinforce our in situ fi ndings, co-cultures of J774A.1 macrophages and U937 cells (ratio 1:3) were treated with etoposide to selectively induce U937 apoptosis. After 5 hours, cells were embedded in paraffi n, sectioned and immunostained in the same way as tissue. Cleaved PARP-1 and caspase-3 positive AC were not phagocytized by macrophages as shown for tissue ( Figure 3A,B) . However, in contrast to apoptotic cells in tonsils or atherosclerotic plaques, most TUNEL positive U937 cells were not phagocytized by macrophages ( Figure 3C , arrows). Although this would be indicative of poor phagocytosis, preliminary experiments showed that phagocytosis should occur within the timeframe studied. Moreover, etoposide did not affect the phagocytosis capacity of the macrophage (data not shown). It is likely that the macrophages were overwhelmed by the massive induction of apoptosis in U937 cells. Indeed, by increasing the ratio of macrophages versus AC from 1:3 to 10:1, TUNEL-positive U937 cells, but not cleaved PARP-1 or caspase-3-positive cells, could be readily detected inside macrophages ( Figure 3D ). This limitation should be taken into account when studying phagocytosis of AC in vitro.
It is important to note that the TUNEL technique is easily prone to false positive staining, most notably after enhanced transcription (Kockx et al. 1998) or during induction of necrotic cell death (de Torres et al. 1997; Grasl-Kraupp et al. 1995; van Lookeren and Gill, 1996) . If results are diffi cult to interpret, tissue analysis by electron microscopy is recommended to examine morphological features of apoptotic cells. Also of note, anti-CD68 antibodies are not macrophage-specifi c but may crossreact with fi broblasts and activated endothelial cells (Beranek, 2005; Kunisch et al. 2004) . Moreover, CD68 is expressed in retinal epithelial cells, vascular smooth muscle cells, osteoblasts and fi broblast-like cells from the bone marrow. Since cross-reactivity depends on the epitope that is recognized by the antibody, stainings patterns may differ when using different anti-CD68 clones. Anti-CD68 clone PG-M1 used in this study exhibits the lowest crossreactivity with other cell types (0% of endothelial cells and less than 2% of synovial, gingival and skin fi broblasts) (Kunisch et al. 2004) and may therefore be the best choice to identify macrophages in different human tissues. To exclude nonspecifi c staining in human plaques and tonsils, we identifi ed CD68 positive cells more thoroughly using other cell type specifi c markers (Figure 4) . Anti-vimentin antibody, which is commonly used to identify fi broblasts, did not stain CD68 positive cells in carotid plaques or tonsil specimens. Similar results were obtained with antibodies directed against von Willebrand Factor and α-SMC-actin which are routinely used for the detection of endothelial cells and smooth muscle cells, respectively. It should be noted that during atherogenesis endothelial cells show enhanced vWF deposition (De Meyer et al. 1999) , which may explain the additional staining of the subendothelial layer of the plaque ( Figure 4G) .
Apoptotic DNA degradation, as detected by TUNEL, may occur via two different mechanisms: within AC by caspase-activated DNase (CAD) and/or within the phagocyte by lysosomal DNase II after phagocytosis of AC (Nagata et al. 2003) . Unlike DNase II, DNase I does not play a signifi cant role in apoptotic DNA laddering as DNase I -/-mice do not display altered chromatin breakdown during apoptosis (Napirei et al. 2004 ). DNase I is mainly found in body fl uids such as serum and urine. It degrades chromatin in necrotic cells and has a main function in breakdown of dietary DNA within the alimentary tract (Napirei et al. 2004) . Colocalization studies indicate that only a small fraction of the TUNEL-labeled nuclei in tonsils were cleaved caspase-3 positive (data not shown). This fi nding suggests rapid breakdown of cleaved caspase-3 (and probably also cleaved PARP-1) by phagosomal pH or lysosomal enzymes, once the AC is engulfed by the macrophage. On the other hand, TUNEL reactivity of AC can be a consequence of engulfment by the macrophage and degradation of the genomic DNA by DNase II. Both theories support the general assumption that TUNEL is the best method to detect phagocytosis of AC in situ. Another explanation for the lack of colocalization between TUNEL and cleaved caspase-3/PARP-1 immunostaining is the time lag between caspase-3 activation and CAD-dependent DNA fragmentation. One may assume that macrophages are able to recognize AC in a very early stage of apoptosis so that AC are engulfed before DNA fragmentation occurs. In line with this theory, Denecker et al. (2000) demonstrated that cell membrane properties that serve as eat-me signals (e.g. exposure of PS) change immediately after initiation of apoptosis, thus before cytochrome c release and activation of caspases can be detected. However, others showed that PS exposure on the apoptotic cell is blocked by the pan-caspase inhibitor z-VAD-fmk and therefore lies downstream from caspase activation. Moreover, these fi ndings are cell culture observations. It remains unclear how effi cient AC are recognized in tissue. As yet, we have no evidence for early recognition of AC in plaques or tonsils.
In conclusion, unremoved TUNEL-positive AC represent a pathological condition and are indicative of poor phagocytosis by macrophages. Other markers for apoptosis, such as cleavage of caspase-3 or PARP-1, should not be used to assess phagocytosis effi ciency, since activation of the caspase cascade and cleavage of their substrates can occur in AC when they have not yet been phagocytized by macrophages. Immunohistochemical analysis of human carotid plaque (upper panels) and tonsil (lower panels) using cell type specifi c markers. The anti-CD68 antibody (PG-M1) strongly stained macrophages (red) in the plaque (A) and in the tonsil (B). The same regions did not show reactivity with the smooth muscle cell marker α-SMC-actin (C-D) and the fi broblast marker vimentin (E-F). The anti-von Willibrand Factor antibody clearly stained the endothelial cells (red) in the plaque (G) whereas germinal centers in tonsils (H) were negative. Panels I and J respectively showed an area with positive α-SMC-actin staining in the plaque and positive vimentin staining in the tonsil that did not colocalize with CD68 positive cells. Bar = 30 µm.
